Caris Life Sciences, Inc. Revenue 2023–2025
Caris Life Sciences, Inc. annual/quarterly revenue history and growth rate from 2023 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Caris Life Sciences, Inc. revenue for the quarter ending March 31, 2026 was 216.2 M, a 78.78% increase year-over-year.
- Caris Life Sciences, Inc. revenue for the twelve months ending March 31, 2026 was 735.3 M.
- Caris Life Sciences, Inc. annual revenue for 2025 was 812.0 M, a 96.97% increase from 2024.
- Caris Life Sciences, Inc. annual revenue for 2024 was 412.3 M, a 34.67% increase from 2023.
- Caris Life Sciences, Inc. annual revenue for 2023 was 306.1 M.
Caris Life Sciences, Inc. (CAI) — Frequently Asked Questions
Caris Life Sciences, Inc. (CAI) is a publicly traded US company. It has a market capitalization of $2.98B. In fiscal 2025 it reported revenue of $812M and net income of -$68M. Explore CAI's stock price, financial statements, earnings history, margins and key ratios below.
What is Caris Life Sciences, Inc.'s market cap?
Caris Life Sciences, Inc. (CAI) has a market capitalization of $2.98B.
What is the CAI stock price?
CAI trades at $17.80 (+3.76% on the day).
How much revenue does Caris Life Sciences, Inc. make?
Caris Life Sciences, Inc. reported revenue of $812M in fiscal 2025.
Is CAI profitable?
In fiscal 2025, Caris Life Sciences, Inc. reported net income of -$68M.